Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookStandard Treatment Guidelines (STG) and The National Essential Drug List for Tanzania (NEDLIT) (WHO; 1997; 210 pages)
View the documentFOREWORD
View the documentACKNOWLEDGMENTS
View the documentINTRODUCTION
close this folderStandard Treatment Guidelines (STG)
Open this folder and view contents1. GASTROINTESTINAL CONDITIONS
Open this folder and view contents2. RESPIRATORY DISEASES
close this folder3. OBSTETRIC AND GYNAECOLOGICAL CONDITIONS AND CONTRACEPTION
Open this folder and view contents3.1 Infection of the Genital Urinary Tact
View the document3.2 Abortion
View the document3.3 Prolonged Rupture Of Membrane (PROM)
View the document3.4 Prophylaxis for Caesarian Section
View the document3.5 Nausea and Vomiting in Pregnancy
View the document3.6 Anaemia During Pregnancy
Open this folder and view contents3.7 Hypertension in Pregnancy
View the document3.8 Diabetes in Pregnancy
View the document3.9 Anaesthesia, Analgesia, Antacids
View the document3.10 Steroids in Respiratory Distress Syndrome
View the document3.11 Myometrial Stimulants (Oxytocics)
View the document3.12 Uterine Stimulation After Delivery
View the document3.13 Myometrial Relaxants (Stimulants)
View the document3.14 Termination of Pregnancy
View the document3.15 Drugs in Pregnancy and Lactation
View the document3.16 Pelvic Inflammatory Diseases
Open this folder and view contents3.17 Hormonal Contraceptives
View the document3.18 Antepartum Haemorrhage (APH)
View the document3.19 Dysmenorrhoea
View the document3.20 Infertility
Open this folder and view contents4. CARDIOVASCULAR DISEASES
Open this folder and view contents5. MALARIA
Open this folder and view contents6. SKIN DISEASES
Open this folder and view contents7. SEXUALLY TRANSMITTED INFECTIONS / DISEASES (STD)
Open this folder and view contents8. DENTAL AND ORAL CONDITIONS
Open this folder and view contents9. GENITO-URINARY DISEASES: KIDNEY CONDITIONS
Open this folder and view contents10. EAR, NOSE AND THROAT CONDITIONS
Open this folder and view contents11. EYE CONDITIONS
Open this folder and view contents12. TUBERCULOSIS AND LEPROSY
Open this folder and view contents13. MUSCULOSKELETAL CONDITIONS AND JOINT DISEASES
Open this folder and view contents14. METABOLIC AND ENDOCRINE SYSTEM CONDITIONS
Open this folder and view contents15. CENTRAL NERVOUS SYSTEM DISEASE CONDITIONS
Open this folder and view contents16. OTHER DISEASE CONDITIONS
Open this folder and view contents17. VIRAL INFECTIONS
Open this folder and view contents18. ALLERGIC REACTIONS
Open this folder and view contents19. NUTRITIONAL AND HAEMATOLOGIC CONDITIONS
Open this folder and view contents20. MALIGNANT DISEASE CONDITIONS
Open this folder and view contents21. INJURIES AND TRAUMA
View the document22. FOREIGN BODIES
View the document23. PAIN
View the document24. POISONING
View the document25. NORMAL LABORATORY VALUES
Open this folder and view contentsNATIONAL ESSENTIAL DRUG LIST
View the documentABBREVIATIONS AND SYMBOLS
 

3.19 Dysmenorrhoea

Clinical features: Dysmenorrhoea is painful menstruation. Dysmenorrhoea is present if pain prevents normal activity and requires medication. There are 3 types of dysmenorrhoea:

Primary (no organic cause), Secondary pathological cause e.g PID and uterine polyposis and membranous (cast of endometrial cavity shed as a single entity (rare). Typically, in primary dysmenorrhoea pain occurs on the first day of menses, usually about the time the flow begins, but it may not be present until the second day. Nausea and vomiting, diarrhoea and headache may occur.

Treatment guidelines

Allow bed rest.

Analgesics such as

Ibuprofen 200-600 mg every 8 hours (maximum 2.4 g/day).

OR


Acetylsalicylic acid 300-600 mg every 4 hours

OR


Diclofenace 25 mg 2-3 times a day


Women with regular complaints can easily detect length of use during their periods (2-3 days usually sufficient)

Treat the underlying condition if known.

NOTE: For primary dysmenorrhoea patients may be adviced to start taking Ibuprofen one or two days before menses and continue for three to four days: during menses to minimise painful menstruation

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French